1-methyl-4-phenyl-2,3-dihydropyridinium has been researched along with Idiopathic Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunner, T; Cirri, E; Ferger, B; Friemel, A; Hiller, K; Karreman, C; Leist, M; Marx, A; Meiser, J; Möller, HM; Odermatt, M; Pape, R; Pasquarelli, N; Ringwald, M; Schildknecht, S; Strittmatter, T | 1 |
| Coates, PW; Everse, J | 1 |
| Beckley, DJ; Bloem, BR; Remler, MP; Roos, RA; van Dijk, JG; Zwinderman, AH | 1 |
3 other study(ies) available for 1-methyl-4-phenyl-2,3-dihydropyridinium and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Astrocytes; Biological Transport; Catecholamines; Cell Line; Cell Membrane; Diffusion; Dopaminergic Neurons; Extracellular Fluid; Humans; Monoamine Oxidase; Oxidation-Reduction; Parkinson Disease; Pyridinium Compounds | 2015 |
The cytotoxic activity of lactoperoxidase: enhancement and inhibition by neuroactive compounds.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Aspirin; Brain; Catalysis; Cell Line, Tumor; Dogs; Dopamine; Erythrocytes; Free Radicals; Herbicides; Humans; Lactoperoxidase; Neurons; Parkinson Disease; Peroxidase; Pyridinium Compounds; Spectrophotometry; Time Factors; Uric Acid | 2004 |
Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease.
Topics: Adult; Aged; Dopamine Agents; Female; Humans; Male; Middle Aged; Motor Skills; Parkinson Disease; Postural Balance; Posture; Pyridinium Compounds | 1996 |